160 related articles for article (PubMed ID: 23124746)
1. Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli.
Yu BJ; Kim JA; Ju HM; Choi SK; Hwang SJ; Park S; Kim E; Pan JG
J Microbiol; 2012 Oct; 50(5):785-91. PubMed ID: 23124746
[TBL] [Abstract][Full Text] [Related]
2. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China.
Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J
Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474
[TBL] [Abstract][Full Text] [Related]
4. Plasmid selection in Escherichia coli using an endogenous essential gene marker.
Goh S; Good L
BMC Biotechnol; 2008 Aug; 8():61. PubMed ID: 18694482
[TBL] [Abstract][Full Text] [Related]
5. Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes.
Tansirichaiya S; Reynolds LJ; Cristarella G; Wong LC; Rosendahl K; Roberts AP
Microb Drug Resist; 2018 Mar; 24(2):105-112. PubMed ID: 28604259
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.
Curiao T; Marchi E; Viti C; Oggioni MR; Baquero F; Martinez JL; Coque TM
Antimicrob Agents Chemother; 2015; 59(6):3413-23. PubMed ID: 25824225
[TBL] [Abstract][Full Text] [Related]
7. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
[TBL] [Abstract][Full Text] [Related]
8. Experimental evolution in morbidostat reveals converging genomic trajectories on the path to triclosan resistance.
Leyn SA; Zlamal JE; Kurnasov OV; Li X; Elane M; Myjak L; Godzik M; de Crecy A; Garcia-Alcalde F; Ebeling M; Osterman AL
Microb Genom; 2021 May; 7(5):. PubMed ID: 33945454
[TBL] [Abstract][Full Text] [Related]
9. Effects of lysine 2-hydroxyisobutyrylation on bacterial FabI activity and resistance to triclosan.
Zheng Y; Dong H; Bai X; Cui H; Li MJ; Wu HY; Zhang K
Biochimie; 2021 Mar; 182():197-205. PubMed ID: 33485933
[TBL] [Abstract][Full Text] [Related]
10. A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.
El-Attar LM; Scott S; Goh S; Good L
Vaccine; 2012 Feb; 30(9):1702-9. PubMed ID: 22212129
[TBL] [Abstract][Full Text] [Related]
11. FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium-Copy Number Plasmids in Escherichia coli.
Ali SA; Chew YW
PLoS One; 2015; 10(6):e0129547. PubMed ID: 26057251
[TBL] [Abstract][Full Text] [Related]
12. Impact of triclosan adaptation on membrane properties, efflux and antimicrobial resistance of Escherichia coli clinical isolates.
Sonbol FI; El-Banna TE; Abd El-Aziz AA; El-Ekhnawy E
J Appl Microbiol; 2019 Mar; 126(3):730-739. PubMed ID: 30431693
[TBL] [Abstract][Full Text] [Related]
13. Non-antibiotic antimicrobial triclosan induces multiple antibiotic resistance through genetic mutation.
Lu J; Jin M; Nguyen SH; Mao L; Li J; Coin LJM; Yuan Z; Guo J
Environ Int; 2018 Sep; 118():257-265. PubMed ID: 29902774
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.
McMurry LM; Oethinger M; Levy SB
FEMS Microbiol Lett; 1998 Sep; 166(2):305-9. PubMed ID: 9770288
[TBL] [Abstract][Full Text] [Related]
15. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
16. Triclosan and antimicrobial resistance in bacteria: an overview.
Yazdankhah SP; Scheie AA; Høiby EA; Lunestad BT; Heir E; Fotland TØ; Naterstad K; Kruse H
Microb Drug Resist; 2006; 12(2):83-90. PubMed ID: 16922622
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis of triclosan-susceptible and -tolerant Escherichia coli O157:H19 in response to triclosan exposure.
Lenahan M; Sheridan Á; Morris D; Duffy G; Fanning S; Burgess CM
Microb Drug Resist; 2014 Apr; 20(2):91-103. PubMed ID: 24138539
[TBL] [Abstract][Full Text] [Related]
18. TraDIS-Xpress: a high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance.
Yasir M; Turner AK; Bastkowski S; Baker D; Page AJ; Telatin A; Phan MD; Monahan L; Savva GM; Darling A; Webber MA; Charles IG
Genome Res; 2020 Feb; 30(2):239-249. PubMed ID: 32051187
[TBL] [Abstract][Full Text] [Related]
19. The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.
Yogiara ; Mordukhova EA; Kim D; Kim WG; Hwang JK; Pan JG
Bioorg Med Chem Lett; 2020 Dec; 30(24):127651. PubMed ID: 33130290
[TBL] [Abstract][Full Text] [Related]
20. A Novel Benzoxaborole Is Active against Escherichia coli and Binds to FabI.
Mandal S; Parish T
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0262220. PubMed ID: 34152809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
